14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

IMGN Predictions History

6 years ago
JuanC Villegas predicted that IMGN for 2017-07-24 is going $5.88 (3.89%)

6 years ago
JuanC Villegas predicted that IMGN for 2017-07-10 is going $7.82 (6.25%)

6 years ago
JS predicted that IMGN for 2017-07-03 is going $6.97 (-1.97%)

6 years ago
JS predicted that IMGN for 2017-06-28 is going $6.36 (-9.14%)

6 years ago
bbullish2 predicted that IMGN for 2017-06-28 is going $6.78 (3.67%)

6 years ago
Sasha.Koniev.6963 predicted that IMGN for 2017-05-17 is going $5.00 (2.88%)

Rank:

7 years ago
Cameron.Gilchrist.5004 predicted that IMGN for 2017-03-28 is going $3.66 (-1.61%)

Rank:

7 years ago
JS predicted that IMGN for 2017-01-06 is going $2.29 (-3.38%)

7 years ago
YoungBulls predicted that IMGN for 2017-01-06 is going $2.70 (13.92%)

Rank:
Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT